Market Tracker

09/01 6:05pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

44.01
Data as of Aug 29
 +0.44 / +1.01%
Today’s Change
32.35
Today|||52-Week Range
55.99
+10.33%
Year-to-Date

Today’s Trading

Previous close43.57
Today’s open43.64
Day’s range43.19 - 44.08
Volume523,020
Average volume (3 months)995,188
Market cap$5.4B
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)-10.87%
Earnings growth (this year)-56.07%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+27.73%
P/E ratioNM
Price/Sales18.01
Price/Book23.44

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+26.14+28.51%
ICPTIntercept Pharmaceut...+0.62+0.21%
IDXXIDEXX Laboratories I...+0.26+0.21%
ALKSAlkermes Plc+0.25+0.56%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$269.3M
Annual profit (last year)-$62.5M
Net profit margin-23.22%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer &
Secretary
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts